News

Podcast

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Author(s):

Alexandra Gerlach, Associate Editor,Kevin Chen, PharmD

Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Doctor diagnosing patient’s health on asthma, lung disease, COVID-19 or bone cancer illness with radiological chest x-ray film for medical healthcare hospital service - Image credit: Chinnapong | stock.adobe.com
Pharmacist discussing medication with patient | Image Credit: © wichayada - stock.adobe.com
Adult and child hands holding lung, world tuberculosis tb day, world no tobacco day, lung cancer, long covid, COPD, eco air pollution, organ donation concept - Image credit: SewcreamStudio | stock.adobe.com
Asthma COPD Breath Nebulizer And Mask Given By Doctor Or Nurse - Image credit: Angelov | stock.adobe.com
Hematology -- Image credit: DIgilife | stock.adobe.com
Related Content
Doctor diagnosing patient’s health on asthma, lung disease, COVID-19 or bone cancer illness with radiological chest x-ray film for medical healthcare hospital service - Image credit: Chinnapong | stock.adobe.com
July 30th 2025

Astegolimab Reduces COPD Exacerbations in Clinical Trials

Kennedy Ferruggia, Assistant Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
July 29th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Breast cancer cells | Image Credit: © sknab - stock.adobe.com
July 30th 2025

Gedatolisib Doublet, Triplet Regimens Improve PFS in Patients With PIK3CA Wild-Type HR+/HER2– Breast Cancer

Alexandra Gerlach, Associate Editor
COBRRA Trial Results Raise Questions About VTE Management
July 15th 2025

COBRRA Trial Results Raise Questions About VTE Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Detailed yet minimalistic depiction of muscle tissue highlighting protein fibers in a vibrant and clean aesthetic. Space for text in the upper left corner - Image credit: Naret | stock.adobe.com
July 29th 2025

FDA Restricts Elevidys Use Amidst New Safety Concerns

Kennedy Ferruggia, Assistant Editor
Model of chronic kidney disease (CKD) -- Image credit: kanruthai | stock.adobe.com
July 29th 2025

OLC Demonstrates Safety and Tolerability in Patients With CKD and Hyperphosphatemia

Gillian McGovern, Associate Editor